BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9801684)

  • 1. Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis.
    Helmbold P; Hegemann B; Holzhausen HJ; Klapperstück T; Marsch WC
    Arch Dermatol; 1998 Oct; 134(10):1275-8. PubMed ID: 9801684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of adult Langerhans cell histiocytosis with etoposide.
    Tsele E; Thomas DM; Chu AC
    J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide in adult multisystem Langerhans cell histiocytosis: a case report].
    Alioua Z; Hjira N; Oumakhir S; Frikh R; Ghfir M; Rimani M; Sedrati O
    Rev Med Interne; 2006 Aug; 27(8):633-6. PubMed ID: 16631279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
    Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans-cell histiocytosis--excellent response to etoposide.
    Mayou SC; Chu AC; Munro DD; Plowman N
    Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Langerhans cell histiocytosis with independently relapsing lung and liver lesions that was successfully treated with etoposide.
    Konno S; Hizawa N; Betsuyaku T; Yasuo M; Yamamoto H; Koizumi T; Nishimura M
    Intern Med; 2007; 46(15):1231-5. PubMed ID: 17675775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for multisystem Langerhans' cell histiocytosis.
    Katz BZ
    J Pediatr; 2002 Feb; 140(2):280. PubMed ID: 11865293
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral, skin and bone multisystem Langerhans cell histiocytosis and its response to etoposide--a case report.
    Sheehan MP; Chu AC
    Clin Exp Dermatol; 1991 Nov; 16(6):463-6. PubMed ID: 1806325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis.
    Chu T
    Australas J Dermatol; 2001 Nov; 42(4):237-42. PubMed ID: 11903153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone.
    Körholz D; Janssen G; Göbel U
    Pediatr Hematol Oncol; 1997; 14(5):443-9. PubMed ID: 9267876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
    Broadbent V; Pritchard J; Yeomans E
    Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Langerhans cell histiocytosis in children with etoposide.
    Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
    Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report of a rare case of Langerhans-cell histiocytosis of the skull base].
    Krengli M; Boccardi A; Gandini G; Negri G
    Minerva Med; 1996 Mar; 87(3):99-103. PubMed ID: 8668295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
    Yu LC; Shenoy S; Ward K; Warrier RP
    Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
    Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
    Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
    Pedrol E; Estruch R; Marrades RM; Ingelmo M
    Rev Clin Esp; 1991 Apr; 188(6):319. PubMed ID: 1780535
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.